Thomas Cancro - 12 Dec 2022 Form 4 Insider Report for Tabula Rasa HealthCare, Inc.

Reporting relationship: CHIEF FINANCIAL OFFICER
Issuer ticker: N/A
Reported as of: 12 Dec 2022
Net transaction value: +$49,910
SEC form: 4
Accepted by SEC: 14 Dec 2022, 15:59:01 UTC
Prior SEC filing: 04 Mar 2022
Next SEC filing: 21 Apr 2023
Source filing: View source filing
Reporting owner signature: /s/ Brian W. Adams, by Power of Attorney

Key filing fact

Thomas Cancro filed Form 4 for Tabula Rasa HealthCare, Inc. on 14 Dec 2022.

Key facts

This page summarizes Thomas Cancro's Form 4 filing for Tabula Rasa HealthCare, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Dec 2022, 15:59.

Change

Previous filing in this sequence was filed on 04 Mar 2022.
Current net transaction value: +$49,910.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TRHC transaction

Common Stock

Purchase

Transaction value: $49,910
Shares: +11,500
Change %: +5.8%
Price: $4.34
Shares after: 211,500
Date: 12 Dec 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $4.30 to $4.35, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote (1).